Solar Pharma shares fell after Q1 revenue dropped 20 per cent YoY. Strong return ratios and regular progress might supply an opportunity for long-term buyers.
Solar Pharma share worth slips 4% after Q1 miss
Leave a comment
Search
Solar Pharma shares fell after Q1 revenue dropped 20 per cent YoY. Strong return ratios and regular progress might supply an opportunity for long-term buyers.
